Keros Therapeutics last closed at $11.52 (+1.41%) on 2026-10-05. Signals today: Golden cross, VCP. Listed on Nasdaq. Trailing 12 months PER is -2.7×. Its overall grade ranks 502 of 741 stocks in Healthcare.
About this company
Keros Therapeutics last closed at $11.52 (+1.41%) on 2026-10-05. Signals today: Golden cross, VCP. Listed on Nasdaq.
Details →Reported results
Position in sector
Healthcare · Overall C+ · 502/741
Valuation grade B-
Related stocks
- NovartisCompetitor
면역·혈액질환 치료제 개발에서 경쟁 가능한 대형 제약사
- Bristol Myers SquibbCompetitor
혈액암·면역학 신약 경쟁 구도에서 비교되는 글로벌 제약사
- Sotatercept(ActRII/activin pathway) 관련 개발사Related theme
Keros의 리간드 트랩/조절인자 계열 접근과 같은 TGF-β/activin 경로 치료제 테마
About Keros Therapeutics
- What technical signals does Keros Therapeutics (KROS) have?
- Keros Therapeutics current technical signals: golden cross (5_20, 0d ago).
- Is Keros Therapeutics a cup-and-handle pattern?
- No. Keros Therapeutics has no valid Cup signal right now.
- What published figures are available for Keros Therapeutics?
- Market cap: $350.97M. Trailing 12 months PER: -2.7×. Latest quarter PBR: 0.87×. Dividend yield: 0.00%.
Like these rules? Backtest them.
Run this signal on this ticker in the free backtest builder — same window, no install.
Backtest this rule ↗Major stocks in the same sector
2026-10-06 dataset
Turn what you saw on this name into a strategy
Ask Q about Keros Therapeutics, or open the plan table on the main site.
From the names you found to a trading rule
Tell Q about the stocks you found to place orders with your conditions.